Cite
Validation of a focus reduction neutralization test (FRNT) to rapidly titrate human SARS-CoV-2 neutralizing antibodies by using the CTL Immunospot S6 universal analyzer
MLA
Ilaria Puglia, et al. “Validation of a Focus Reduction Neutralization Test (FRNT) to Rapidly Titrate Human SARS-CoV-2 Neutralizing Antibodies by Using the CTL Immunospot S6 Universal Analyzer.” Heliyon, vol. 10, no. 15, Aug. 2024. EBSCOhost, https://doi.org/10.1016/j.heliyon.2024.e34925.
APA
Ilaria Puglia, Marialuigia Caporale, Claudia Casaccia, Fabrizia Valleriani, Romolo Salini, Shadia Berjaoui, Cristina Marfoglia, Lucilla Ricci, & Alessio Lorusso. (2024). Validation of a focus reduction neutralization test (FRNT) to rapidly titrate human SARS-CoV-2 neutralizing antibodies by using the CTL Immunospot S6 universal analyzer. Heliyon, 10(15). https://doi.org/10.1016/j.heliyon.2024.e34925
Chicago
Ilaria Puglia, Marialuigia Caporale, Claudia Casaccia, Fabrizia Valleriani, Romolo Salini, Shadia Berjaoui, Cristina Marfoglia, Lucilla Ricci, and Alessio Lorusso. 2024. “Validation of a Focus Reduction Neutralization Test (FRNT) to Rapidly Titrate Human SARS-CoV-2 Neutralizing Antibodies by Using the CTL Immunospot S6 Universal Analyzer.” Heliyon 10 (15). doi:10.1016/j.heliyon.2024.e34925.